Literature DB >> 10820536

Melanocytoma of the ciliary body diagnosed by fine-needle aspiration biopsy.

S M El-Harazi1, J Kellaway, R L Font.   

Abstract

A 55-yr-old African American man was referred for evaluation of a mass involving the anterior choroid/ciliary body in his left eye. Dilated fundus examination revealed a large, deeply pigmented mass associated with an exudative retinal detachment. Ultrasonography demonstrated an elevated mass which involved the anterior uvea and showed low reflectivity by standardized A-scan. Cytologic examination of fine needle aspiration (FNA) biopsy from the tumor was interpreted as a melanocytoma. The patient developed a total retinal detachment and secondary glaucoma which led to enucleation of the eye. Histopathologic examination confirmed the diagnosis of melanocytoma. To our knowledge, this is the first report in which the diagnosis of uveal melanocytoma was established by FNA biopsy and later confirmed histopathologically. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10820536     DOI: 10.1002/(sici)1097-0339(200006)22:6<394::aid-dc13>3.0.co;2-7

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Iris melanocytoma in child diagnosed by fine needle aspiration biopsy.

Authors:  Samira Awaji; Hind Alkatan; Soliman Al-Kharashi; Ali Al-Rajhi
Journal:  Saudi J Ophthalmol       Date:  2013-08-03

3.  Acute subconjunctival pigmentation with an underlying ciliary body mass: An unusual case presentation.

Authors:  Hind M Alkatan; Amany A Fathaddin; Ammar Al Mahmood; Hala A Helmi; Khalid Emara
Journal:  Saudi J Ophthalmol       Date:  2019-07-17

4.  Commentary: Vitrectomy as a treatment modality in vitreous seeding secondary to ciliary body melanocytoma.

Authors:  Pukhraj Rishi
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.